- $2.48bn
- $2.05bn
- $2.12bn
Annual cashflow statement for Privia Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -191 | -12.1 | 21 | 17 | 29.7 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 254 | 68 | 37.1 | 56.7 | 71.1 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 18 | -6.35 | 8.66 | 19.5 | 41.8 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 55.1 | 47.2 | 80.8 | 109 | 163 |
| Capital Expenditures | -0.547 | -0.104 | -0.113 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -32.2 | 0 | -42.9 | -12 | -182 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -32.8 | -0.104 | -43 | -12 | -182 |
| Financing Cash Flow Items | -13 | 0.125 | -5.04 | 1.65 | -1.34 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 214 | -19.7 | 3.71 | 4.33 | 6.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 236 | 27.4 | 41.5 | 102 | -11.5 |